Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | WDR5 | P61964 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
| ▸ | LDHA | P00338 | 1/20 | 0.48 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.47 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.44 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.44 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | KDM2B | Q8NHM5 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL295041 | 0.86 | TSHR (0.54) | TSHRCYP2A6CYP1A2HPGDMAPT | |
| SCHEMBL11266839 | 0.84 | TSHR (0.52) | TSHRCYP2A6CYP1A2HPGDMAPT | |
| SCHEMBL248146 | 0.84 | WDR5 (0.66) | TSHRCYP2A6CYP1A2HPGDALDH1A1 | |
| SCHEMBL6908614 | 0.82 | WDR5 (0.63) | TSHRCYP2A6CYP1A2HPGDALDH1A1 | |
| SCHEMBL6915351 | 0.82 | WDR5 (0.63) | TSHRCYP2A6CYP1A2HPGDALDH1A1 | |
| SCHEMBL6917503 | 0.82 | WDR5 (0.63) | TSHRCYP2A6CYP1A2HPGDALDH1A1 | |
| SCHEMBL6917500 | 0.82 | WDR5 (0.63) | TSHRCYP2A6CYP1A2HPGDALDH1A1 | |
| SCHEMBL6912830 | 0.82 | WDR5 (0.63) | TSHRCYP2A6CYP1A2HPGDALDH1A1 | |
| SCHEMBL1394794 | 0.82 | ALDH1A1 (0.49) | TSHRCYP2A6CYP1A2HPGDMAPT | |
| SCHEMBL8679415 | 0.82 | TSHR (0.50) | TSHRCYP2A6CYP1A2HPGDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109761775-B | Method for purifying 4-acetyl-1-methylnaphthalene from acetyl methylnaphthalene mixture | 湖北海力环保科技股份有限公司 | 2022-02-01 | — | — | CN | claimed |
| JP-4364152-A | — | — | None | — | — | JP | disclosed |
| CN-109761775-B | Method for purifying 4-acetyl-1-methylnaphthalene from acetyl methylnaphthalene mixture | 湖北海力环保科技股份有限公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-109761775-B | Method for purifying 4-acetyl-1-methylnaphthalene from acetyl methylnaphthalene mixture | 湖北海力环保科技股份有限公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-109761775-B | Method for purifying 4-acetyl-1-methylnaphthalene from acetyl methylnaphthalene mixture | 湖北海力环保科技股份有限公司 | 2022-02-01 | — | — | CN | disclosed |
| US-20080132562-A1 | TETRONIC AND TETRAMIC ACIDS | GODEL THIERRY | 2008-06-05 | — | — | US | disclosed |
| US-20080132562-A1 | TETRONIC AND TETRAMIC ACIDS | GODEL THIERRY | 2008-06-05 | — | — | US | disclosed |
| US-20070197524-A1 | Fluorenes and carbazoles as ligands of the EP2 receptor | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-08-23 | — | — | US | disclosed |
| US-20070197524-A1 | Fluorenes and carbazoles as ligands of the EP2 receptor | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-08-23 | — | — | US | disclosed |
| WO-2007071456-A1 | FLUORENES AND CARBAZOLES AS LIGANDS OF THE EP2 RECEPTOR | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-06-28 | — | — | WO | disclosed |
| JP-H04364152-A | METHOD FOR RECOVERING CATALYST | TEIJIN LTD | 1992-12-16 | — | — | JP | disclosed |
| US-5138098-A | Catalytic actlation using complexing agent | AMOCO CORPORATION (US) | 1992-08-11 | — | — | US | disclosed |
| US-5026917-A | Acetylation of 2-methylnaphthalenes | AMOCO CORPORATION (US) | 1991-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080132562-A1 | TETRONIC AND TETRAMIC ACIDS | BACE1, PSEN1, BACE2 | TSHR 412/4885CYP2A6 1345/4885CYP1A2 2117/4885 |
| US-20070197524-A1 | Fluorenes and carbazoles as ligands of the EP2 receptor | PTGER2, PTGER1, PTGDR2 | TSHR 207/4885CYP2A6 434/4885CYP1A2 108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.